Edgewise Therapeutics (EWTX) News Today → After Conviction, More Bad News for Trump (From Paradigm Press) (Ad) Free EWTX Stock Alerts $17.66 +0.05 (+0.28%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 2, 2024 | marketbeat.comSwiss National Bank Acquires Shares of 50,100 Edgewise Therapeutics, Inc. (NASDAQ:EWTX)Swiss National Bank acquired a new stake in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 50,100 shares of the company's stock, valued at approximJune 1, 2024 | marketbeat.com55,591 Shares in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Purchased by Trexquant Investment LPTrexquant Investment LP purchased a new position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 55,591 shares of the companyMay 23, 2024 | marketbeat.com47,100 Shares in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Bought by Jump Financial LLCJump Financial LLC purchased a new stake in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 47,100 shares of the cMay 14, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Sutro Biopharma (STRO), Edgewise Therapeutics (EWTX) and Forte Biosciences (FBRX)May 10, 2024 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Stock Price Down 6.1%Edgewise Therapeutics (NASDAQ:EWTX) Trading Down 6.1%May 10, 2024 | finance.yahoo.comEdgewise Therapeutics Inc (EWTX) Reports First Quarter 2024 Financial ResultsMay 10, 2024 | businesswire.comEdgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 15, 2024May 9, 2024 | investorplace.comEWTX Stock Earnings: Edgewise Therapeutics Beats EPS for Q1 2024May 9, 2024 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Shares Gap Down to $20.89Edgewise Therapeutics (NASDAQ:EWTX) Shares Gap Down to $20.89May 7, 2024 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Reaches New 1-Year High at $21.51Edgewise Therapeutics (NASDAQ:EWTX) Reaches New 1-Year High at $21.51May 6, 2024 | businesswire.comEdgewise Therapeutics Doses First Patient in Phase 2 CIRRUS-HCM Trial of EDG-7500 in Obstructive Hypertrophic Cardiomyopathy (HCM)May 4, 2024 | insidertrades.comInsider Selling: Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Insider Sells 1,718 Shares of StockMay 3, 2024 | marketbeat.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) Insider Behrad Derakhshan Sells 1,718 SharesEdgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) insider Behrad Derakhshan sold 1,718 shares of the stock in a transaction on Thursday, May 2nd. The stock was sold at an average price of $18.91, for a total transaction of $32,487.38. Following the completion of the sale, the insider now directly owns 13,422 shares of the company's stock, valued at $253,810.02. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.May 1, 2024 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Sets New 1-Year High at $20.90Edgewise Therapeutics (NASDAQ:EWTX) Reaches New 12-Month High at $20.90April 30, 2024 | marketbeat.comabrdn plc Makes New $1.65 Million Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)abrdn plc bought a new position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 150,418 shares of the company's stock, vApril 29, 2024 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Trading 6.3% Higher Edgewise Therapeutics (NASDAQ:EWTX) Trading Up 6.3%April 23, 2024 | businesswire.comEdgewise Receives European Medicines Agency (EMA) Orphan Drug Designations for Sevasemten (EDG-5506) for the Treatment of Becker and Duchenne Muscular DystrophiesApril 22, 2024 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Shares Gap Up After Analyst UpgradeEdgewise Therapeutics (NASDAQ:EWTX) Shares Gap Up on Analyst UpgradeApril 22, 2024 | marketbeat.comRoyal Bank of Canada Boosts Edgewise Therapeutics (NASDAQ:EWTX) Price Target to $32.00Royal Bank of Canada increased their price target on shares of Edgewise Therapeutics from $28.00 to $32.00 and gave the company an "outperform" rating in a research report on Monday.April 22, 2024 | seekingalpha.comJANX Janux Therapeutics, Inc.April 18, 2024 | marketbeat.comVontobel Holding Ltd. Makes New Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)Vontobel Holding Ltd. acquired a new position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The fund acquired 327,801 shares of the company's stock, valued at approximately $3,586,000. Vontobel Holding Ltd.April 17, 2024 | investing.comEdgewise reports positive Becker trial results, plans discussionApril 17, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Edgewise Therapeutics (EWTX) and Progyny (PGNY)April 17, 2024 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Given Buy Rating at Truist FinancialTruist Financial restated a "buy" rating and set a $25.00 price objective on shares of Edgewise Therapeutics in a research note on Wednesday.April 17, 2024 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Stock Price Down 3.4%Edgewise Therapeutics (NASDAQ:EWTX) Trading Down 3.4%April 16, 2024 | marketbeat.comEdgewise Therapeutics' (EWTX) Outperform Rating Reaffirmed at WedbushWedbush restated an "outperform" rating and issued a $26.00 price target on shares of Edgewise Therapeutics in a research report on Tuesday.April 15, 2024 | businesswire.comEdgewise Therapeutics Announces Positive Two-Year Topline Results from the ARCH Open Label Trial of Sevasemten (EDG-5506) in Adults with Becker Muscular Dystrophy (Becker)April 15, 2024 | marketbeat.comShort Interest in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Expands By 27.7%Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) was the recipient of a large increase in short interest in the month of March. As of March 31st, there was short interest totalling 5,720,000 shares, an increase of 27.7% from the March 15th total of 4,480,000 shares. Currently, 9.1% of the shares of the company are sold short. Based on an average daily volume of 1,010,000 shares, the short-interest ratio is presently 5.7 days.April 5, 2024 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Trading Up 4.2%Edgewise Therapeutics (NASDAQ:EWTX) Shares Up 4.2%April 4, 2024 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Trading Down 5.6%Edgewise Therapeutics (NASDAQ:EWTX) Trading Down 5.6%March 30, 2024 | marketbeat.comShort Interest in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Decreases By 17.9%Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) was the target of a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 4,480,000 shares, a decrease of 17.9% from the February 29th total of 5,460,000 shares. Based on an average trading volume of 1,050,000 shares, the days-to-cover ratio is presently 4.3 days. Currently, 7.1% of the company's shares are sold short.March 28, 2024 | businesswire.comEdgewise Therapeutics Announces Upcoming Podium Presentation at the American College of Cardiology's 2024 Annual Scientific SessionMarch 27, 2024 | businesswire.comEdgewise Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium on April 2, 2024March 18, 2024 | marketbeat.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) Sees Significant Increase in Short InterestEdgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) was the target of a large increase in short interest in February. As of February 29th, there was short interest totalling 5,460,000 shares, an increase of 6.4% from the February 14th total of 5,130,000 shares. Approximately 9.1% of the shares of the company are sold short. Based on an average daily trading volume, of 967,100 shares, the short-interest ratio is currently 5.6 days.March 18, 2024 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Stock Price Down 5.8%Edgewise Therapeutics (NASDAQ:EWTX) Shares Down 5.8%March 15, 2024 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Stock Price Up 5.2%Edgewise Therapeutics (NASDAQ:EWTX) Trading Up 5.2%March 7, 2024 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Coverage Initiated by Analysts at Piper SandlerPiper Sandler initiated coverage on Edgewise Therapeutics in a research report on Thursday. They set an "overweight" rating and a $48.00 price objective for the company.March 5, 2024 | finance.yahoo.comEdgewise Therapeutics to Present at the Leerink Partners Global Biopharma Conference on March 11, 2024March 3, 2024 | marketbeat.comFmr LLC Lowers Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)Fmr LLC lessened its position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 13.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 6,402,847 shares of the company's stock after selling 954,642 sharesFebruary 28, 2024 | businesswire.comEdgewise Therapeutics to Present on EDG-5506 for the Treatment of Becker Muscular Dystrophy at the 2024 MDA Clinical and Scientific ConferenceFebruary 26, 2024 | finance.yahoo.comWall Street Analysts Predict a 52.78% Upside in Edgewise Therapeutics, Inc. (EWTX): Here's What You Should KnowFebruary 25, 2024 | investing.comEdgewise Therapeutics earnings missed by $0.04, revenue was in line with estimatesFebruary 24, 2024 | msn.comEdgewise Therapeutics (EWTX) Price Target Increased by 8.00% to 27.54February 22, 2024 | benzinga.comEdgewise Therapeutics Stock (NASDAQ:EWTX), Short Interest ReportFebruary 22, 2024 | benzinga.comEdgewise Therapeutics: Q4 Earnings InsightsFebruary 22, 2024 | msn.comEdgewise Therapeutics Non-GAAP EPS of $0.47February 22, 2024 | finance.yahoo.comEdgewise Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business HighlightsFebruary 22, 2024 | businesswire.comEdgewise Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business HighlightsFebruary 22, 2024 | investing.comEdgewise Therapeutics Inc (EWTX)February 22, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Edgewise Therapeutics (EWTX), Bicycle Therapeutics (BCYC) Get Edgewise Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Time is Running Out - June 25th Deadline Approaching! (Ad)If you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you must get in now. Don’t delay. See all the details you need here. EWTX Media Mentions By Week EWTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EWTX News Sentiment▼1.800.73▲Average Medical News Sentiment EWTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EWTX Articles This Week▼22▲EWTX Articles Average Week Get Edgewise Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Kura Oncology News Today Arcturus Therapeutics News Today AnaptysBio News Today Heron Therapeutics News Today MaxCyte News Today Solid Biosciences News Today Gossamer Bio News Today PMV Pharmaceuticals News Today Blueprint Medicines News Today Viking Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EWTX) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | Sponsored